Related Experiment Video
Updated: Aug 5, 2025

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy
Published on: December 4, 2010
COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report
Konstantin E Belozerov1, Ilia S Avrusin1, Lyubov I Andaryanova1
1Hospital Pediatry, Saint Petersburg State Pediatric Medical University, 194100 Saint Petersburg, Russia.
Insights
COVID-19 in children can cause serious vasculitis affecting multiple organs, including skin and the central nervous system. Early diagnosis and treatment with steroids and immunomodulators are crucial for managing this life-threatening condition.
Area of Science:
- Pediatric Rheumatology
- Infectious Diseases
- Vascular Medicine
Background:
- Limited data exists on COVID-19-associated vasculopathy in children.
- Skin and central nervous system involvement has been reported.
- This study describes cases of pediatric vasculitis linked to COVID-19.
Purpose of the Study:
- To characterize COVID-19-associated vasculitis in pediatric patients.
- To describe the clinical presentation, affected systems, and treatment outcomes.
Main Methods:
- Retrospective-prospective case series.
- Inclusion of four pediatric patients with confirmed COVID-19-associated vasculitis.
- Morphological description and etiological confirmation via RT-PCR on tissue biopsy.
Main Results:
- Skin (100%), respiratory (75%), and cardiovascular (50%) systems were most frequently involved.
- All patients exhibited elevated inflammatory markers and D-dimer.
- Diagnoses included polyarteritis nodosa (50%), Henoch-Schonlein purpura (25%), and unclassified vasculitis (25%).
- Treatment involved systemic glucocorticosteroids, DMARDs, and in some cases, IVIG or biologics (etanercept, tocilizumab, adalimumab).
Conclusions:
- COVID-19-associated vasculitis can be life-threatening in children.
- SARS-CoV-2 may act as a trigger for vasculitis and immune-mediated diseases.
- Further research and case collection are necessary to understand this condition.
Background:
Several cases of skin and central nervous system vasculopathy associated with COVID-19 in children have been published, but the information is rather limited. Our study aimed to describe these cases of vasculitis associated with COVID-19 in children.
Methods:
In the retrospective-prospective case series study we included information regarding four children with COVID-19-associated vasculitis. In every case, we had a morphological description and the etiology was confirmed via real-time polymerase chain reaction during a tissue biopsy.
Results:
The most involved systems were skin (4/4), respiratory (3/4), cardiovascular (2/4), nervous (1/4), eye (1/4), kidney (1/4), and inner year (1/4). All patients had increased inflammatory markers and thrombotic parameters (D-dimer). No patient met the criteria for multisystem inflammatory syndrome in children. Two patients met polyarteritis nodosa criteria, one met Henoch-Schonlein purpura criteria, and one met unclassified vasculitis criteria. All patients were treated with systemic glucocorticosteroids (two-pulse therapy). Non-biologic DMARDs were prescribed in all cases; 1/4 patients (25%) was treated with intravenous immunoglobuline, and 3/4 (75%) were treated with biologics (etanercept, tocilizumab, and adalimumab).
Conclusions:
Vasculitis associated with COVID-19 could be a life-threatening condition; SARS-CoV-2 might be a new trigger or etiological agent for vasculitis and other immune-mediated diseases. Further research and collection of similar cases are required.
More Related Videos
08:01Detection of Human Immunodeficiency Virus Type 1 HIV-1 Antisense Protein ASP RNA Transcripts in Patients by Strand-Specific RT-PCR
Published on: November 27, 2019
04:43Author Spotlight: Optimizing Digital Droplet PCR Method for Accurate Adeno-Associated Viral Genome Quantification
Published on: October 11, 2024
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis II: Clinical Features and Diagnostic Tests